Scientists are racing to develop a safe, effective, vaccine for COVID-19 – but will people be willing to take it when it's available? We already have a flu vaccine, but less than half of Americans get it each year. Gretchen Chapman, PhD, a cognitive psychologist who studies health behavior, discusses why people choose to get vaccinated–or not–and how policym ... Show More
Yesterday
Precision mental health and personalized treatment, with Leanne Williams, PhD, and Zachary Cohen, PhD
Depression and anxiety look very different from one person to the next, and finding the right treatment can be a trial-and-error process. But researchers are working to change that. Leanne Williams, PhD, and Zachary Cohen, PhD, discuss the emerging field of precision or personali ... Show More
42m 9s
Jan 7
How will AI companions change our human relationships? With Ashleigh Golden, PsyD, and Rachel Wood, PhD
What does it mean to have an AI boyfriend or girlfriend, or to turn to an AI friend for emotional support? Ashleigh Golden, PsyD, and Rachel Wood, PhD, discuss the rise of AI companions and how they may change our human relationships; the differences – and overlap – between AI co ... Show More
47m 44s
Dec 31
Encore: The benefits of being bilingual, with Viorica Marian, PhD
More than half the world’s population speaks more than one language. Viorica Marian, PhD, of Northwestern University, talks about why speaking multiple languages may have far-reaching cognitive benefits, how the bilingual brain processes language, and how the languages we speak s ... Show More
45m 47s
Dec 2020
COVID-19 Chapter 13: Vaccines, Take 2
<p>We’re back with another episode in our Anatomy of a Pandemic series on COVID-19. This time, our subject matter is the one everyone has been waiting for: vaccines. In this episode, with the help of two amazing guests, we attempt to answer all of your burning questions about the ... Show More
1h 19m
Sep 2020
What We Can't Know About a Vaccine
The race for a COVID-19 vaccine entered a new phase recently. Four different vaccine candidates, developed by Moderna, Pfizer, BionTech and Johnson & Johnson, entered final-stage trials, with two others close behind. But we won’t know exactly how these four vaccines work for mont ... Show More
13m 57s